Prime Minister Sanae Takaichi got her start in politics as an intern for a trailblazing Colorado lawmaker. She returns to Washington this week to meet with President Trump.
Stay informed with Globe News — bringing you trusted stories and global perspectives that matter. Explore the world, one headline at a time!
Prime Minister Sanae Takaichi got her start in politics as an intern for a trailblazing Colorado lawmaker. She returns to Washington this week to meet with President Trump.
Crypto scammers are using OpenClaw’s popularity to target developers via a new GitHub phishing campaign designed to drain their crypto wallets. Summary Attackers are impersonating OpenClaw on GitHub, creating fake
A Coinbase user’s attempt to block an IRS summons for his financial records was blocked by a California court. Summary A California court dismissed a Coinbase user’s attempt to block
XRP focused treasury firm Evernorth has officially filed with the SEC to go public on Nasdaq. Summary Evernorth filed a Form S 4 with the SEC, moving closer to its
A fresh Western Disturbance will keep rain and snowfall activity going across Jammu and Kashmir for the next 36 hours. The rain activity won’t be continuous – there will be
Bitcoin price erased all of its gains from this week as it crashed to a critical support level amid hotter-than-expected PPI data and Jerome Powell’s Federal Reserve speech that cast
Two setups “Opinons are a dime a dozen” Veteran trader and classical chartist Peter Brandt has urged Bitcoin maximalists to stop exhibiting dogmatic behavior. In his latest market commentary, Brandt
Ripple expands into Brazil with full-stack institutional platform Ripple Labs announced a major expansion of its operations into Brazil. Expansion. The company is rolling out a comprehensive platform combining custody, prime
As the asset struggles to sustain momentum above the $1.50 mark, XRP is once again nearing a turning point in its current market cycle. The wider technical structure indicates that
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.





